529 related articles for article (PubMed ID: 30826269)
21. Clinical and genetic investigation of a Japanese family with cardiac fabry disease. Identification of a novel α-galactosidase A missense mutation (G195V).
Nakagawa N; Maruyama H; Ishihara T; Seino U; Kawabe J; Takahashi F; Kobayashi M; Yamauchi A; Sasaki Y; Sakamoto N; Ota H; Tanabe Y; Takeuchi T; Takenaka T; Kikuchi K; Hasebe N
Int Heart J; 2011; 52(5):308-11. PubMed ID: 22008442
[TBL] [Abstract][Full Text] [Related]
22. [Cardiac manifestations of Anderson-Fabry disease and efficacy of enzyme replacement therapy].
Hagège A
Rev Med Interne; 2010 Dec; 31 Suppl 2():S238-42. PubMed ID: 21211672
[TBL] [Abstract][Full Text] [Related]
23. Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment.
Niemann M; Herrmann S; Hu K; Breunig F; Strotmann J; Beer M; Machann W; Voelker W; Ertl G; Wanner C; Weidemann F
JACC Cardiovasc Imaging; 2011 Jun; 4(6):592-601. PubMed ID: 21679893
[TBL] [Abstract][Full Text] [Related]
24. Fabry disease presenting as apical left ventricular hypertrophy in a patient carrying the missense mutation R118C.
Caetano F; Botelho A; Mota P; Silva J; Leitão Marques A
Rev Port Cardiol; 2014 Mar; 33(3):183.e1-5. PubMed ID: 24661928
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-Fabry disease.
Deva DP; Hanneman K; Li Q; Ng MY; Wasim S; Morel C; Iwanochko RM; Thavendiranathan P; Crean AM
J Cardiovasc Magn Reson; 2016 Mar; 18():14. PubMed ID: 27036375
[TBL] [Abstract][Full Text] [Related]
26. Cardiac Phenotype of Prehypertrophic Fabry Disease.
Nordin S; Kozor R; Baig S; Abdel-Gadir A; Medina-Menacho K; Rosmini S; Captur G; Tchan M; Geberhiwot T; Murphy E; Lachmann R; Ramaswami U; Edwards NC; Hughes D; Steeds RP; Moon JC
Circ Cardiovasc Imaging; 2018 Jun; 11(6):e007168. PubMed ID: 29853467
[TBL] [Abstract][Full Text] [Related]
27. Fabry Disease in Families With Hypertrophic Cardiomyopathy: Clinical Manifestations in the Classic and Later-Onset Phenotypes.
Adalsteinsdottir B; Palsson R; Desnick RJ; Gardarsdottir M; Teekakirikul P; Maron M; Appelbaum E; Neisius U; Maron BJ; Burke MA; Chen B; Pagant S; Madsen CV; Danielsen R; Arngrimsson R; Feldt-Rasmussen U; Seidman JG; Seidman CE; Gunnarsson GT
Circ Cardiovasc Genet; 2017 Aug; 10(4):. PubMed ID: 28798024
[TBL] [Abstract][Full Text] [Related]
28. Predictors of Clinical Evolution in Prehypertrophic Fabry Disease.
Camporeale A; Pieroni M; Pieruzzi F; Lusardi P; Pica S; Spada M; Mignani R; Burlina A; Bandera F; Guazzi M; Graziani F; Crea F; Greiser A; Boveri S; Ambrogi F; Lombardi M
Circ Cardiovasc Imaging; 2019 Apr; 12(4):e008424. PubMed ID: 30943767
[TBL] [Abstract][Full Text] [Related]
29. Myocardial Edema, Myocyte Injury, and Disease Severity in Fabry Disease.
Augusto JB; Nordin S; Vijapurapu R; Baig S; Bulluck H; Castelletti S; Alfarih M; Knott K; Captur G; Kotecha T; Ramaswami U; Tchan M; Geberhiwot T; Fontana M; Steeds RP; Hughes D; Kozor R; Moon JC
Circ Cardiovasc Imaging; 2020 Mar; 13(3):e010171. PubMed ID: 32114828
[TBL] [Abstract][Full Text] [Related]
30. [Isolated left ventricular hypertrophy : is it a Fabry disease?].
Barbey F; Dormond O; Monzambani V; Barbey G; Namdar M; Monney P
Rev Med Suisse; 2020 Oct; 16(709):1886-1890. PubMed ID: 33026733
[TBL] [Abstract][Full Text] [Related]
31. Comparison of left atrial size and function in hypertrophic cardiomyopathy and in Fabry disease with left ventricular hypertrophy.
Saccheri MC; Cianciulli TF; Challapa Licidio W; Lax JA; Beck MA; Morita LA; Gagliardi JA;
Echocardiography; 2018 May; 35(5):643-650. PubMed ID: 29457264
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and Clinical Characteristics of Fabry Disease in Chinese Patients With Hypertrophic Cardiomyopathy.
Xiao Y; Sun Y; Tian T; Wang TJ; Zhao RX; Zhang Y; Wang LP; Liu YX; Lu CX; Zhou XL; Yang WX
Am J Med Sci; 2021 Sep; 362(3):260-267. PubMed ID: 34266644
[TBL] [Abstract][Full Text] [Related]
33. Atypical patterns of cardiac involvement in Fabry disease.
Coughlan JJ; Elkholy K; O'Brien J; Kiernan T
BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 26989114
[TBL] [Abstract][Full Text] [Related]
34. When should cardiologists suspect Anderson-Fabry disease?
Gambarin FI; Disabella E; Narula J; Diegoli M; Grasso M; Serio A; Favalli BM; Agozzino M; Tavazzi L; Fraser AG; Arbustini E
Am J Cardiol; 2010 Nov; 106(10):1492-9. PubMed ID: 21059442
[TBL] [Abstract][Full Text] [Related]
35. Hypertrophic obstructive cardiomyopathy caused by Fabry disease: implications for surgical myectomy.
Frustaci A; Borghetti V; Pentiricci S; Verardo R; Scialla R; Russo MA
ESC Heart Fail; 2023 Dec; 10(6):3710-3713. PubMed ID: 37715354
[TBL] [Abstract][Full Text] [Related]
36. [Heart involvement in Anderson-Fabry disease: Italian recommendations for diagnostic, follow-up and therapeutic management].
Pieruzzi F; Pieroni M; Zachara E; Marziliano N; Morrone A; Cecchi F
G Ital Cardiol (Rome); 2015 Nov; 16(11):630-8. PubMed ID: 26571477
[TBL] [Abstract][Full Text] [Related]
37. The Prevalence of Fabry Disease Among Turkish Patients with Non-Obstructive Hypertrophic Cardiomyopathy: Insights from a Screening Study.
Barman HA; İkitimur B; Kılıçkıran Avcı B; Durmaz E; Atıcı A; Aslan S; Ceylaner S; Karpuz H
Balkan Med J; 2019 Oct; 36(6):354-358. PubMed ID: 31446751
[TBL] [Abstract][Full Text] [Related]
38. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
Maron MS; Finley JJ; Bos JM; Hauser TH; Manning WJ; Haas TS; Lesser JR; Udelson JE; Ackerman MJ; Maron BJ
Circulation; 2008 Oct; 118(15):1541-9. PubMed ID: 18809796
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy.
Kubo T; Ochi Y; Baba Y; Hirota T; Tanioka K; Yamasaki N; Yoshimitsu M; Higuchi K; Takenaka T; Nakajima K; Togawa T; Tsukimura T; Sano S; Tei C; Sakuraba H; Kitaoka H
J Cardiol; 2017 Jan; 69(1):302-307. PubMed ID: 27554049
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy.
Sachdev B; Takenaka T; Teraguchi H; Tei C; Lee P; McKenna WJ; Elliott PM
Circulation; 2002 Mar; 105(12):1407-11. PubMed ID: 11914245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
